Microbiology of catheter associated bloodstream infection: differences according to catheter type.

Catheter-associated bloodstream infection epidemiology hospital-acquired infection infection prevention and control nosocomial infection

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
27 Sep 2024
Historique:
received: 27 06 2024
revised: 04 09 2024
accepted: 16 09 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 29 9 2024
Statut: aheadofprint

Résumé

Catheter-associated bloodstream infections (CABSI) cause preventable morbidity. We compared the microbiological aetiology of CABSI across different types of central and peripherally inserted catheters. We analysed prospectively collected CABSI data in a 2100-bed hospital network in Switzerland between 2016 and 2022. We included: short-term non-tunnelled central venous catheters (CVC); long-term catheters (tunnelled, or peripherally inserted central catheters); arterial catheters; dialysis catheters; and peripheral venous catheters (PVC). We used multivariable logistic regression models to describe risk of Staphylococcus aureus and Gram-negative pathogens according to catheter type. 416 CABSI episodes were included, including 60 episodes of S. aureus and 92 episodes of Gram-negative CABSI. Microbiological profile differed between catheter types. Together, PVC and dialysis catheters accounted for 43/60 (72%) of all S. aureus CABSI. After adjusting for age, sex and haematology/oncology care, odds of S. aureus were higher for haemodialysis catheters (OR 17.3, 95% CI 5.75-52.2, p <0.01) and PVC (OR 2.96, 95% CI 1.22-7.20, p=0.02) compared to short-term non-tunnelled CVC. Odds of Gram-negative organism as cause of CABSI were higher in long-term catheters versus short-term non-tunnelled CVC (OR 2.70, 95% CI 1.37-5.24). CABSI in catheters other than short-term non-tunnelled CVC are more commonly caused by virulent organisms including S. aureus and Gram-negative bacteria. Catheter type should be considered when selecting empirical antimicrobial therapies.

Identifiants

pubmed: 39343125
pii: S1201-9712(24)00318-7
doi: 10.1016/j.ijid.2024.107247
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107247

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Auteurs

Aleece MacPhail (A)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Department of Infectious Diseases, Monash Health, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: aleece.macphail@monash.edu.

Marie-Noëlle Chraïti (MN)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Marie-Céline Zanella (MC)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Nasreen Hassoun-Kheir (N)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Gaud Catho (G)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Aude Nguyen (A)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Stephan Harbarth (S)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Niccolò Buetti (N)

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France.

Classifications MeSH